These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17353673)

  • 41. Reducing CVD risk.
    Aranjo C
    Aust Fam Physician; 2008 Sep; 37(9):695. PubMed ID: 18837159
    [No Abstract]   [Full Text] [Related]  

  • 42. Risk factors of Hong Kong Chinese patients with coronary heart disease.
    Chair SY; Lee SF; Lopez V; Ling EM
    J Clin Nurs; 2007 Jul; 16(7):1278-84. PubMed ID: 17584346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperlipidemia and cardiovascular disease.
    Malloy MJ; Kane JP
    Curr Opin Lipidol; 2012 Dec; 23(6):591-2. PubMed ID: 23160407
    [No Abstract]   [Full Text] [Related]  

  • 44. Alcohol and cardiovascular diseases.
    Klatsky AL
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):499-506. PubMed ID: 19419257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Editorial: hypertensiology].
    Hitzenberger G
    Wien Med Wochenschr; 2008; 158(13-14):357-8. PubMed ID: 18677584
    [No Abstract]   [Full Text] [Related]  

  • 46. Cardiovascular disease in diabetes.
    Bloomgarden ZT
    Diabetes Care; 2008 Jun; 31(6):1260-6. PubMed ID: 18509144
    [No Abstract]   [Full Text] [Related]  

  • 47. Improving lipid goal attainment: is it enough?
    Gotto AM
    Circulation; 2009 Jul; 120(1):3-5. PubMed ID: 19546383
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand.
    Tanomsup S; Aekplakorn W; Sritara P; Woodward M; Yamwong S; Tunlayadechanont S; Tatsaneeyapan A; Lim S; Rajatanavin R
    Diabetes Care; 2007 Aug; 30(8):2138-40. PubMed ID: 17468343
    [No Abstract]   [Full Text] [Related]  

  • 49. CUORE: a sustainable cardiovascular disease prevention strategy.
    Giampaoli S
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):161-2. PubMed ID: 17446792
    [No Abstract]   [Full Text] [Related]  

  • 50. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperlipidaemia and cardiovascular disease.
    Curr Opin Lipidol; 1998 Aug; 9(4):345-60. PubMed ID: 9739491
    [No Abstract]   [Full Text] [Related]  

  • 52. Gender differences in cardiovascular disease prevention.
    Jackson G
    Menopause Int; 2008 Mar; 14(1):13-7. PubMed ID: 18380955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperlipidemia and cardiovascular disease: cardiovascular update.
    Le NA
    Curr Opin Lipidol; 2008 Oct; 19(5):545-7. PubMed ID: 18769239
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyperlipidemia and cardiovascular disease: new insights on lipoprotein(a).
    Burkhardt R
    Curr Opin Lipidol; 2019 Jun; 30(3):260-261. PubMed ID: 31045609
    [No Abstract]   [Full Text] [Related]  

  • 55. Carotid endarterectomy in the elderly: are the patient characteristics, the early outcome, and the predictors the same as those in younger patients?
    Debing E; Van den Brande P
    Surg Neurol; 2007 May; 67(5):467-71; discussion 471. PubMed ID: 17445605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular risk assessment and hyperlipidemia.
    Becker J
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):277-85. PubMed ID: 18644510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular disease in chronic kidney disease.
    Saran AM; DuBose TD
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):425-34. PubMed ID: 19124439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.